Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01475565 · ClinicalTrials.gov registry record

Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome

A clinical trial, sponsored by Virginia Commonwealth University.

Terminated
Registry status
2
Enrollment target

NCT01475565 is a clinical trial that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01475565 was terminated before completion, sponsored by Virginia Commonwealth University.

TERMINATED
Registry status
2 participants
Enrollment target

Study Summary

The polycystic ovary syndrome (PCOS) affects about 10% of reproductive-age women. Women with PCOS are at a higher risk of gestational diabetes, which may lead to more pregnancy complications. It is unknown if there are factors that may predict which women are more at risk. The goal of this study is to evaluate the risk factors of gestational diabetes, such as dietary and physical activity factors, race, and how the body handles its own hormones during pregnancy. Our long term goal is to contribute in finding ways to successfully prevent gestational diabetes.

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2013-05
Est. Completion 2014-08

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT01475565

The ClinicalTrials.gov registry entry for NCT01475565 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01475565 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01475565 about?

NCT01475565 is a clinical study titled "Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome". The polycystic ovary syndrome (PCOS) affects about 10% of reproductive-age women. Women with PCOS are at a higher risk of gestational diabetes, which may lead to more pregnancy complications. It is unknown if there are factors that may predict which women are more at risk. The goal of this study is...

What is the current status of trial NCT01475565?

This trial is currently terminated. The enrollment target is 2 participants. The study started on 2013-05. Estimated completion is 2014-08.

Who is sponsoring clinical trial NCT01475565?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.